PHRM Phorm Corp

TIDMPHRM

RNS Number : 8890S

Phorm Corporation Limited

13 November 2013

13 November 2013

Phorm Corporation Limited ("Phorm" or the "Company")

Statement re: Share Price Movement

Phorm (AIM: PHRM), the personalisation technology company, notes the recent movements in the Company's share price and, apart from the strong and continuing commercial progress previously announced, knows of no operational reasons for the price movement.

As stated in the Company's interim results released on 30 September 2013, the Company requires additional funding during this quarter. The Company is in advanced discussions with a number of parties from both the US and the UK regarding such funding and will update the market on such funding in due course.

For Enquiries

Phorm Corporation Limited

Andy Croxson (analysts & investors) +44 207 297 2067

UK Investors

Mirabaud Securities LLP +44 20 7321 2508 (Joint Broker)

Jason Woollard

Peter Krens

Liberum Capital +44 20 3100 2222 (Nominated Advisor and Joint Broker)

Chris Bowman

Richard Bootle

US Investors

Lippert Heilshorn and Associates +1 212 838 3777 (Investor Relations)

John Heilshorn

- ends -

About Phorm

Phorm is a global personalisation technology company that makes content and advertising more relevant to the consumer. Phorm's innovative platform preserves user privacy and delivers a more interesting online experience.

Phorm's partners include leading Internet Service Providers (ISPs), Publishers, Ad Networks and Advertisers.

A Singapore incorporated company, Phorm (under a previous holding company) was admitted to the AIM market of the London Stock Exchange in 2004.

For more information, please visit: www.phorm.com

This information is provided by RNS

The company news service from the London Stock Exchange

END

SPMGRBDBBBBBGXX

Phorm Corp (LSE:PHRM)
Historical Stock Chart
From Jun 2024 to Jul 2024

Phorm Corp (LSE:PHRM)
Historical Stock Chart
From Jul 2023 to Jul 2024